What's breaking now, across thousands of outlets.
More than 90 lawsuits against GLP-1 companies claim rare eye condition resulted from diabetes and weight loss drugs.
We haven't written up this one. Al Jazeera has the full story — the link below goes straight to it.
This is one outlet's version. Read the fullest account.
Biopharmaceutical firm Specialised Therapeutics extended its commercial agreement with Incyte Biosciences to handle regulatory registration distribution and commercialisation of ruxolitinib cream in…
Following transcatheter aortic valve implantation (TAVI), disturbances in the heart's electrical conduction system can make a pacemaker necessary.
State laws to combat disability-based discrimination in the organ transplant process aren't working, according to new research from The Ohio State University College of Medicine.
[New Era] Namibia is currently grappling with an acute shortage of 330 regional social workers, including community liaison officers, administrative officers and support staff, to help deliver…
Plus news about Boehringer, Envisagenics, Ionis, Otsuka, Merck, Lexeo and Mantle. Amgen gets a win from Horizon buyout: Amgen said dazodalibep, a CD40 ligand antagonist, succeeded in a Phase ...
The Drugs Controller General of India advises that all non-steroidal anti-inflammatory drugs (NSAIDs) and antibiotics must be sold and distributed only on the prescription of a registered medical…
